Cargando…

Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes

The biology of tumor-derived exosomes (TEX) is only partially understood and much remains to be studied in order to define the effect that the tumor microenvironment or the activation of tumor cells exerts on their composition and functions. Increased expression and activity of toll-like receptor 4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domenis, Rossana, Cifù, Adriana, Marinò, Daniele, Fabris, Martina, Niazi, Kayvan R., Soon-Shiong, Patrick, Curcio, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560033/ https://www.ncbi.nlm.nih.gov/pubmed/31186484 http://dx.doi.org/10.1038/s41598-019-44949-y

Ejemplares similares

Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes
por: Domenis, Rossana, et al.
Publicado: (2018)

Circulating exosomes express α(4)β(7) integrin and compete with CD4+ T cells for the binding to Vedolizumab
por: Domenis, Rossana, et al.
Publicado: (2020)

Pro-Inflammatory Microenvironment Modulates the Transfer of Mutated TP53 Mediated by Tumor Exosomes
por: Domenis, Rossana, et al.
Publicado: (2021)

Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis
por: Domenis, Rossana, et al.
Publicado: (2017)

The Influence of a Stressful Microenvironment on Tumor Exosomes: A Focus on the DNA Cargo
por: Domenis, Rossana, et al.
Publicado: (2020)

Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia
por: Quartuccio, Luca, et al.
Publicado: (2021)

Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma
por: Cifù, Adriana, et al.
Publicado: (2023)

Ceramide releases exosomes with a specific miRNA signature for cell differentiation
por: Fiorani, Federico, et al.
Publicado: (2023)

Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells
por: Cifù, A., et al.
Publicado: (2019)

The Exposure to Osteoarthritic Synovial Fluid Enhances the Immunomodulatory Profile of Adipose Mesenchymal Stem Cell Secretome
por: Cifù, Adriana, et al.
Publicado: (2020)

ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease
por: Janes, Francesco, et al.
Publicado: (2019)

Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven et al. Joint Bone Spine 2021;88:105258
por: De Marchi, Ginevra, et al.
Publicado: (2022)

Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies
por: Fabris, Martina, et al.
Publicado: (2017)

Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells
por: Domenis, Rossana, et al.
Publicado: (2017)

Immune Responses against SARS-CoV-2—Questions and Experiences
por: Mangge, Harald, et al.
Publicado: (2021)

Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients
por: Fabris, Martina, et al.
Publicado: (2022)

High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients
por: Fabris, Martina, et al.
Publicado: (2022)

Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples
por: Givechian, Kevin B., et al.
Publicado: (2018)

The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
por: Sozio, Emanuela, et al.
Publicado: (2023)

Author Correction: The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
por: Sozio, Emanuela, et al.
Publicado: (2023)

Validation of a One-Step Reverse Transcription-Droplet Digital PCR (RT-ddPCR) Approach to Detect and Quantify SARS-CoV-2 RNA in Nasopharyngeal Swabs
por: Mio, Catia, et al.
Publicado: (2021)

Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Exosome-Mediated Immunosuppression in Tumor Microenvironments
por: Xie, Qi-Hui, et al.
Publicado: (2022)

Yersinia V–Antigen Exploits Toll-like Receptor 2 and CD14 for Interleukin 10–mediated Immunosuppression
por: Sing, Andreas, et al.
Publicado: (2002)

Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
por: Curci, Debora, et al.
Publicado: (2021)

More insights into the immunosuppressive potential of tumor exosomes
por: Huber, Veronica, et al.
Publicado: (2008)

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
por: Gabitzsch, Elizabeth, et al.
Publicado: (2021)

The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia
por: Graziano, Elena, et al.
Publicado: (2022)

An Immunosuppressive Tick Salivary Gland Protein DsCystatin Interferes With Toll-Like Receptor Signaling by Downregulating TRAF6
por: Sun, Ta, et al.
Publicado: (2018)

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
por: John, Liza B, et al.
Publicado: (2013)

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab
por: Quartuccio, Luca, et al.
Publicado: (2023)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Immunosuppressive Exosomes: A New Approach for Treating Arthritis
por: Yang, Chenjie, et al.
Publicado: (2012)

Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis
por: Cosenza, Stella, et al.
Publicado: (2018)

Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy
por: Wang, Tingting, et al.
Publicado: (2022)

Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
por: Ripoll, Juan G., et al.
Publicado: (2022)

Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates
por: Wille-Reece, Ulrike, et al.
Publicado: (2006)

The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
por: Petes, Carlene, et al.
Publicado: (2017)

Critical immunosuppressive effect of MDSC-derived exosomes in the tumor microenvironment
por: Rashid, Mohammad H., et al.
Publicado: (2021)

Toll-Like Receptors in Atherosclerosis
por: Falck-Hansen, Mika, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3t0mnfibo4754pmntvhke38bre